FABIANI HAILS ANTI-HIV RESEARCH BY EAST KILBRIDE PHARMACEUTICAL PIONEERS

Following a visit to East Kilbride pharmaceutical product company Controlled Therapeutics Ltd, Linda Fabiani MSP has congratulated the firm on its work to develop drug delivery technologies to help prevent the transmission of HIV/AIDS.

Controlled Therapeutics has entered into a development programme in partnership with an American not-for-profit product development organisation to assess whether its new polymer drug delivery system can be used by women to help protect themselves against HIV infection.

Central Scotland MSP Ms Fabiani has previously cited the success of Controlled Therapeutics during Scottish Parliament debates about the role of scientific innovation in the Scottish economy. Speaking after her visit to the company’s East Kilbride premises, Ms Fabiani said,

“Controlled Therapeutics is a real success story for East Kilbride and Scotland. It was fascinating to hear about how a product developed right here in East Kilbride’s science park is now the world’s leading obstetric brand, used every minute of every day to assist a woman in giving birth, in over 50 countries.

“I’m very heartened that such a successful company is now putting its expertise to work to help tackle one of the biggest problems facing the developing world, the spread of HIV infection.

“Controlled Therapeutics’ partnership with the highly respected reproductive health and HIV prevention agency CONRAD has the potential to transform the health and welfare of women across the world by giving them the ability to take action to protect themselves against HIV.

“This pioneering collaboration is something for East Kilbride to be proud of. I wish Dr Cameron Macdonald and his team at Controlled Therapeutics every success and am really looking forward to hearing about the progress of this project.”